Endplate morphology affects the risk of complications by changing the grafted bony occupancy rate in OLIF patients

椎体终板形态通过改变OLIF患者的植骨骨占用率影响并发症风险。

阅读:1

Abstract

BACKGROUND: Large contact areas between the grafted bone and the bony endplate (BEP) can optimize the load transmission pattern and decrease the risk of non-union and cage subsidence. The relationship between endplate morphology parameters and complications may stem from the difference in contact sufficiency between the grafted bone and BEP. This study was conducted to verify that changes in endplate morphology affect the risk of complications in patients with oblique lumbar interbody fusion (OLIF) by changing the grafted bony occupancy rate (GBOR). METHODS: Imaging data of 95 segments of 75 patients who underwent OLIF were collected retrospectively. Endplate morphology parameters, GBOR values, and complications were measured by computational tomography (CT). RESULTS: The superior endplate was more concave than the inferior endplate was. The GBOR values in the superior endplate were significantly lower than those in the inferior endplate (coronal and sagittal). The relationship between endplate morphology parameters and GBOR values was significant. The nonfusion rate was significantly higher in the superior endplate. A lower GBOR is an independent predictor of non-union and more severe cage subsidence. CONCLUSIONS: Changes in endplate morphology affect the risk of cage subsidence and non-union in patients undergoing OLIF by changing the GBOR. Newly designed OLIF cages with larger concave depths on the superior side and different concave angles should be promoted to optimize the match between the grafted bone and the BEP and improve the prognosis of patients with OLIF. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12891-025-09036-6.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。